BrioHealth Celebrates 100th BrioVAD System Implant Milestone

BrioHealth Solutions announces the successful implantation of its 100th BrioVAD System, an investigational Ventricular Assist Device (VAD) designed to support patients with advanced heart failure. 

At the forefront of mechanical circulatory support, the BrioVAD System is designed to push the boundaries of performance, reliability, and patient-centred care. From comprehensive clinical training and responsive technical support to strong hospital partnerships and long-term program development, BrioHealth's mission goes beyond technology — it includes the commitment to providing best-in-class customer support to advance the VAD field.

"We're tremendously proud of this milestone and represents our strong alignment with our clinical partners toward advancing the VAD field," said Chen Chen, PhD. CEO of BrioHealth Solutions. "Reaching 100 implants underscores not only the dedication of clinicians and patients participating in the study, but also the real promise of BrioVAD System's design to make life with a mechanical heart device more comfortable and sustainable."

Since the program's launch in November 2024, this milestone reflects growing confidence across 34 US INNOVATE Trial locations (The INNOVATE Trial - BrioHealth Solutions) in the BrioVAD System's potential to advance the field of mechanical circulatory support.

"Reaching the 100th BrioVAD System implant is a significant milestone for the clinical community and for patients facing advanced heart failure," said Francis D. Pagani, M.D., PhD, the Otto Gago, M.D., Professor of Cardiac Surgery at the University of Michigan Medical School and the study's National Principal Investigator. "Each success brings us closer to offering a longer, higher-quality life for individuals who once had few options."